Skip to main content
2026 CRT Conference Main banner

CRT 2026

Valve and Structural

Session:: Electrophysiology and IC Left Atrial Appendage Closure Forum Joint Session

Panel Discussion | What Does the Future Hold for LAA Closure?

Sunday, March 8, 2026
5:47 PM - 6:05 PM EST
Location: Georgetown

    Moderator(s)

  • Stefan Bertog, MD

    Cardioligist
    CardioVascular Center Frankfurt
    St Paul, Minnesota, United States

    Disclosure(s): Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing)

  • Devi G. Nair, MD , FACC, FHRS

    Director of Cardiac Electrophysiology
    St. Bernards Medical Center
    JONESBORO, Arkansas, United States

    Disclosure information not submitted.

  • Michael J. Rinaldi, MD

    Director Structural Heart Program
    Sanger Heart and Vascular Institute/Atrium Health
    Charlotte, North Carolina, United States

    Disclosure(s): PiCardia: Consulting Fees (e.g., advisory boards) (Ongoing)

    • Panel Discussant(s)

  • Srinivas Iyengar, MD

    Director, Structural Heart
    Boulder Heart at Anderson Medical Center (Boulder Community Health), Colorado, United States

    Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • Vijay Iyer, MD, PhD

    Associate Professor
    University at Buffalo
    East Amherst, New York, United States

    Disclosure information not submitted.

  • Saurabh Sanon, MD, FACC

    Regional Medical Director, Structural Heart Therapies
    HCA - West Florida Division
    ST. PETERSBURG, Florida, United States

    Disclosure information not submitted.

  • Horst Sievert, MD, FSCAI, FACC, FESC

    Director
    CardioVascular Center Frankfurt CVC
    Frankfurt, Hessen, Germany

    Disclosure(s): Abbott, Ablative Solutions, Adona Medical, Akura Medical, Ancora Heart, Append Medical, Axon, Bavaria Medizin Technologie GmbH, BioRefine, Boston Scientific, Canon, Cardiac Dimensions, Cardiac Success, Cardimed, Cardionovum, Contego, Coramaze: Study honoraria, travel expenses, consulting fees to institution (Ongoing); Croivalve, CSL Behring LLC, CVRx, Dinova, Eclipse, Endobar, Endologix, Endomatic, Esperion Therapeutics, Inc., Hangzhou Nuomao Medtech, Holistick Medical, Intershunt, Intervene, Laminar, Lifetech, Magenta, Maquet Getinge Group, Metavention, Mitralix: Study honoraria, travel expenses, consulting fees to institution (Ongoing); Mokita, Myotec, Neurotronic, Novelrad, NXT Biomedical, Occlutech, Recor, Renal Guard, Shifamed, Terumo, Tonic Medical, Trilio, Trisol, TruLeaf, Vascular Dynamics, Vectorious Medtech, Venus, Venock, Vivasure Medical, Vvital Biomed, Whiteswell, Xenter: Study honoraria, travel expenses, consulting fees to institution (Ongoing)

  • Thomas Waggoner, DO, FACC, FSCAI, FSVM, RPVI

    Director Structural Heart, Director Cardiovascular Research, Direct Advanced Cardiac Fellowships.
    US Heart & Vascular, Tucson Medical Center

    Disclosure(s): No financial relationships to disclose

Disclosure(s):
Stefan Bertog, MD: Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing)
Michael J. Rinaldi, MD: PiCardia: Consulting Fees (e.g., advisory boards) (Ongoing)
Srinivas Iyengar, MD: Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Horst Sievert, MD, FSCAI, FACC, FESC: Abbott, Ablative Solutions, Adona Medical, Akura Medical, Ancora Heart, Append Medical, Axon, Bavaria Medizin Technologie GmbH, BioRefine, Boston Scientific, Canon, Cardiac Dimensions, Cardiac Success, Cardimed, Cardionovum, Contego, Coramaze: Study honoraria, travel expenses, consulting fees to institution (Ongoing); Croivalve, CSL Behring LLC, CVRx, Dinova, Eclipse, Endobar, Endologix, Endomatic, Esperion Therapeutics, Inc., Hangzhou Nuomao Medtech, Holistick Medical, Intershunt, Intervene, Laminar, Lifetech, Magenta, Maquet Getinge Group, Metavention, Mitralix: Study honoraria, travel expenses, consulting fees to institution (Ongoing); Mokita, Myotec, Neurotronic, Novelrad, NXT Biomedical, Occlutech, Recor, Renal Guard, Shifamed, Terumo, Tonic Medical, Trilio, Trisol, TruLeaf, Vascular Dynamics, Vectorious Medtech, Venus, Venock, Vivasure Medical, Vvital Biomed, Whiteswell, Xenter: Study honoraria, travel expenses, consulting fees to institution (Ongoing)
Thomas Waggoner, DO, FACC, FSCAI, FSVM, RPVI: No financial relationships to disclose